Cell and Gene Therapy Market Size, Share & Industry Analysis, By Type (By Cell Therapy {By Therapy Type [CAR-T Cell Therapy, TCR-T Cell Therapy, Natural Killer Cells, &Others], By Product (Kymriah, Yescarta, Tecartus, Breyanzi, Abecma, Carvykti, & Others], By Indication [Oncology & Others]}, and By Gene Therapy {By Vector Type [Viral Vectors & Non-Viral Vectors], By Product Type [Zolgensma, Luxturna, Roctavian, & Others], and By Indication [Genetic Diseases, Ophthalmology, Hematology, & Others]}), By End User (Hospitals & Clinics, Specialty Clinics, & Others), and Regional Forecast, 2026-2034
Last Updated: April 27, 2026
| Format: PDF
| Report ID: FBI114130